PRIMA BIOMED Aktie

0,10 EUR -6,7308%

Zu Ihrem Onlinebroker

kaufen verkaufen

PRIMA BIOMED Aktienkurs : 09:08 ( 15 Min. verzögert)
0,0970 € Letzter Kurs	-6,73% Veränderung	0,104 € Vortag	0,0970 € Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
0,0970 - 0,0970 Tag	0,300 - 0,0950 52 Wochen	0 Tag	5.103 Ø 52 Wochen	0,0970 78.000 Stücke	0,116 65.000 Stücke

PRIMA BIOMED Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

25.05.

Prima BioMed puts LA at centre

THE dual-listed Australian cancer therapy company Prima BioMed has no immediate plans to delist from the Australian stock exchange, despite recently appointing a new chief executive who will...
24.05.

Midday: Aus shares trading flat

Prima BioMed Limited's (ASX:PRR) CEO Martin Rogers has stepped down from his role but will remain on the board as a non-executive director. Current senior executive Matthew Lehman will assume the…

24.05.

Prima BioMed Announces Changes to the Board and Senior Management

SYDNEY, AUSTRALIA, May 23, 2012 (MARKETWIRE via COMTEX) -- Prima BioMed Ltd (asx:PRR) (NASDAQ:PBMD) ("Prima" or the "Company") advises of the following changes to senior management and the board of directors....
04.05.

new 'gift' for cancer sufferers

He is lending his expertise to his brother's project as chairman of the scientific advisory board of the Australian healthcare company, Prima BioMed, that is developing the ovarian cancer vaccine. Neil Frazer is the company's chief medical officer.
03.05.

Prima BioMed to Present at the 37th Annual Deutsche Health Care Conference

SYDNEY, AUSTRALIA, May 03, 2012 (MARKETWIRE via COMTEX) -- Prima BioMed Ltd (NASDAQ:PBMD) (asx:PRR) announced today that Dr. Neil Frazer, Chief Medical Officer, will present at the Deutsche Health Care Conference...